Stocktoria
Oric Pharmaceuticals, Inc. ORIC
Oric Pharmaceuticals, Inc. financials (annual)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating income | -$143.0M | -$142.9M | -$110.8M | -$91.8M | -$78.9M | -$74.2M | -$28.6M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$129.5M | -$127.8M | -$100.7M | -$89.1M | -$78.7M | -$73.7M | -$26.9M |
| EPS (diluted) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 | — | — |
| Operating cash flow | -$111.0M | -$112.7M | -$85.7M | -$75.1M | -$59.5M | -$45.3M | -$23.5M |
| Free cash flow | -$111.7M | -$113.8M | -$86.5M | -$77.2M | -$60.5M | -$45.9M | -$24.3M |
| Cash & equivalents | $45.7M | $59.4M | $23.4M | $66.8M | $226.0M | $78.4M | $89.2M |
| Total assets | $408.9M | $274.1M | $252.0M | $247.2M | $298.6M | $299.0M | $94.1M |
| Total liabilities | $24.5M | $31.0M | $27.9M | $24.8M | $25.7M | $9.2M | $6.1M |
| Shareholders' equity | $384.4M | $243.1M | $224.1M | $222.4M | $273.0M | $289.8M | -$90.1M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.